Meta-analysis · 2026

Review of 21 studies: ketamine linked to large short-term drops in suicidal thinking


Original title
Ketamine treatment alleviates suicide ideation in high-risk populations: a systematic review and meta-analysis.
Authors
Tang W, Jiang WW, Que WQ, et al.
Journal
Epidemiology and psychiatric sciences, 2026
Molecules
Ketamine
Conditions
Suicidal ideation, Depression
Participants
927
Evidence grade
Moderate
Source
Read the original paper

The question

Does ketamine reduce suicidal thinking in people considered at high risk of suicide, and what side effects are reported?

What they did

The researchers searched for double-blind randomized controlled trials and open-label (unblinded) studies published up to October 2025 that tested ketamine for suicidal ideation. They followed standard systematic review reporting guidelines and combined the results statistically. Twenty-one studies with a total of 927 participants met their criteria. They also looked at which participant characteristics were linked to bigger effects.

What they found

Pooled across studies, ketamine was associated with a large reduction in suicidal thinking (standardized mean difference -1.40, 95% confidence interval -2.15 to -0.66, P < 0.001), though the authors graded this as low-quality evidence. Side effects were common: dissociation, a feeling of detachment from oneself or surroundings, was reported by 38.8% of participants, nausea by 31.6%, dizziness by 24.7%, headache by 22.0% and anxiety by 15.8%. The effect appeared stronger in younger people and in those with more severe suicidal thinking.

The fine print

The included studies were a mix of blinded randomized trials and uncontrolled open-label studies, so some of the improvement may reflect expectation or natural recovery rather than the drug. The wide confidence interval suggests results varied a lot between studies, and the authors rated the overall evidence as low quality. The review does not report how long the benefit lasted, and optimal dosing remains unclear. This summary is based on the abstract only.

What it means

Pooled research suggests ketamine is associated with short-term reductions in suicidal thinking among high-risk people, but the underlying evidence is uneven, side effects are frequent, and long-term effects are still unknown.

Evidence grade: Moderate. A meta-analysis that pools both blinded randomized trials and uncontrolled open-label studies, and the authors themselves rated the pooled evidence as low quality.

This summary is based on the study’s published abstract.

Get new studies like this one, explained every two weeks.